Purdue Sues Hospira To Block New Version Of Dilaudid
Purdue lodged a complaint Friday in the U.S. District Court for the Northern District of Illinois seeking to prevent Hospira from marketing an injectable form of the drug.
The complaint was filed by Gregory J. Vogler, John L. Abramic and Kevin A. O’Connor of McAndrews Held & Malloy Ltd.
Stamford, Conn.-based Purdue holds a new drug...
To view the full article, register now.